By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Gradalis Inc. 

2545 Golden Bear Drive
Suite 110
Carrollton  Texas  75006  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
CryoPort Supports Gradalis Inc.'s Vigil Platform In Clinical Trials For Autologous Immunotherapies For Multiple Cancers 1/3/2017 6:47:33 AM
Gradalis Inc. Announces A Novel Combination Study Of Vigil EATC In Women With Advanced Ovarian Cancer 12/21/2016 11:52:25 AM
Gradalis Inc. Announces Research Alliance With Mount Sinai 12/19/2016 11:53:29 AM
Gradalis Inc. Announces The Appointment Of Dr. Brian Daniels To The Newly Formed Scientific Advisory Board 10/25/2016 9:12:34 AM
Gradalis Inc. The Appointment Of Dr. Steven Burakoff To The Newly Formed Scientific Advisory Board 10/19/2016 11:37:21 AM
Gradalis Inc. To Take Part In BIO Investor Forum In San Francisco 10/10/2016 9:07:03 AM
Gradalis Inc. Announces The Appointment Of Sir Marc Feldmann As Chairman Of The Newly Formed Scientific Advisory Board 9/8/2016 8:37:29 AM
Gradalis Inc. Announces Dosing Of First Patient In Pilot Study Combining Vigil Engineered Autologous Tumor Cell Immunotherapy And Durvalumab In Advanced Breast Cancer 8/29/2016 8:39:52 AM
Gradalis Inc. Appoints Martin J. Birkhofer, M.D. Chief Medical Officer 7/26/2016 6:49:12 AM
Gradalis Inc. Announces Presentation Of Data From A Pilot Study Of Vigil Cancer Vaccine In Ewing’s Sarcoma 6/4/2015 7:50:40 AM
12
//-->